Bioventus (BVS) Inventory (2020 - 2026)

Bioventus (BVS) has reported Inventory for 7 consecutive years, with $79.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Inventory fell 17.27% year-over-year to $79.8 million; the trailing twelve-month figure through Jun 2026 stood at $79.8 million (down 17.27% YoY), and the FY2025 full-year result was $82.2 million, down 11.07% from the prior year.
• Inventory eased to $79.8 million in Q2 2026 per BVS's latest filing, from $83.2 million in the prior quarter.
• Across five years, Inventory topped out at $97.6 million in Q3 2023 and bottomed at $64.7 million in Q2 2022.
• Historically, Inventory has averaged $87.1 million across 5 years, with a median of $89.0 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Inventory surged 110.45% in 2022, then declined 17.27% in 2026.
• Over 5 years, Inventory stood at $84.8 million in 2022, then grew by 7.75% to $91.3 million in 2023, then grew by 1.25% to $92.5 million in 2024, then retreated by 11.07% to $82.2 million in 2025, then fell by 2.95% to $79.8 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $79.8 million, $83.2 million, and $82.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.